The frequency of peripheral blood Siglec-7+CD56dimNK cells was decreased in patients with NAFLD with different stages of liver fibrosis, whereas the frequency of dysfunctional Siglec-7−PD-1+CD57+CD56dimNK cells was increased. This evidence concerns the gene B3GAT1 and metabolic dysfunction-associated steatotic liver disease.